Charles R. Schaller

Charles R. Schaller is a declared insider at 2 companies; the most frequent names are Medarex Inc and Celldex Therapeutics, Inc. We count 29 filings; the first trade dates from 17 March 2006 and the latest from 9 September 2010.

On the open market, the record shows 6 purchases worth €84k and 17 sales worth €721k. The net balance comes to €637k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant and 2 option exercises. So far in 2010, the count stands at 1 purchase and no sales.

The median purchase comes to €14k. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 67% of cases, with a median move of +10.8%. They describe history only and say nothing certain about the share price ahead.

On 13 September 2010 came the latest disclosure, an open-market purchase for €14k in Celldex Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.